Lam Research Corporation (LRCX)

Basic

  • Market Cap

    $128.68B

  • EV

    $128.03B

  • Shares Out

    131.1M

  • Revenue

    $14.32B

  • Employees

    17,200

Margins

  • Gross

    45.94%

  • EBITDA

    30.64%

  • Operating

    28.11%

  • Pre-Tax

    27.35%

  • Net

    24.15%

  • FCF

    33.97%

Returns (5Yr Avg)

  • ROA

    16.46%

  • ROTA

    60.03%

  • ROE

    58.37%

  • ROCE

    34.22%

  • ROIC

    41.55%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $887.23

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $5,638.01M

  • Net Debt

    -$654.23M

  • Debt/Equity

    0.61

  • EBIT/Interest

    21.71

Growth (CAGR)

  • Rev 3Yr

    6.27%

  • Rev 5Yr

    5.66%

  • Rev 10Yr

    13.71%

  • Dil EPS 3Yr

    8.68%

  • Dil EPS 5Yr

    8.74%

  • Dil EPS 10Yr

    29.18%

  • Rev Fwd 2Yr

    0.24%

  • EBITDA Fwd 2Yr

    0.39%

  • EPS Fwd 2Yr

    3.17%

  • EPS LT Growth Est

    12.48%

Dividends

  • Yield

  • Payout

    28.72%

  • DPS

    $7.45

  • DPS Growth 3Yr

    14.99%

  • DPS Growth 5Yr

    14.41%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    11.03%

Select a metric from the list below to chart it

Jun '14

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

LTM

Total Revenues

9,653.6

10,044.7

14,626.2

17,227

17,428.5

14,317.1

Total Revenues % Chg.

-12.9%

4.1%

45.6%

17.8%

1.2%

-24.8%

Cost of Goods Sold, Total

5,295.1

5,436

7,820.8

9,355.2

9,573.4

7,740.2

Gross Profit

4,358.5

4,608.7

6,805.3

7,871.8

7,855.1

6,577

Selling General & Admin Expenses, Total

702.4

682.5

829.9

885.7

832.8

829.2

R&D Expenses

1,191.3

1,252.4

1,493.4

1,604.2

1,727.2

1,723.7

Other Operating Expenses, Total

1,893.7

1,934.9

2,323.3

2,490

2,559.9

2,552.9

Operating Income

2,464.7

2,673.8

4,482

5,381.8

5,295.2

4,024

Interest Expense, Total

-117.3

-177.4

-208.6

-184.8

-186.5

-185.4

Interest And Investment Income

98.8

85.4

19.7

15.2

139

212

Net Interest Expenses

-18.5

-92

-188.9

-169.6

-47.5

26.6

Currency Exchange Gains (Loss)

0.8

-3.3

-7

-0.7

-7.1

-3.1

Other Non Operating Income (Expenses)

-0.5

-3.5

84.7

-18.4

-11.1

14.6

EBT, Excl. Unusual Items

2,446.6

2,575

4,370.8

5,193.1

5,229.5

4,062.1

Restructuring Charges

-120.3

-146.9

Merger & Related Restructuring Charges

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

Asset Writedown

Other Unusual Items

EBT, Incl. Unusual Items

2,446.6

2,575

4,370.8

5,193.1

5,109.2

3,915.2

Income Tax Expense

255.1

323.2

462.3

587.8

598.3

457

Earnings From Continuing Operations

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,458.2

Net Income

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,458.2

Net Income to Common Incl Extra Items

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,458.2

Net Income to Common Excl. Extra Items

2,191.4

2,251.8

3,908.5

4,605.3

4,510.9

3,458.2

Total Shares Outstanding

144.4

145.3

142.5

137

133.3

131.3

Weighted Avg. Shares Outstanding

152.5

144.8

143.6

139.9

135.5

133.3

Weighted Avg. Shares Outstanding Dil

159.9

149.1

145.3

140.6

135.8

133.8

EPS

14.4

15.5

27.2

32.9

33.3

25.9

EPS Diluted

13.7

15.1

26.9

32.8

33.2

25.9

EBITDA

2,774

2,942.3

4,789.2

5,715.6

5,637.6

4,386.7